Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB09078 | Lenvatinib | 0 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 0 | Completed | 1 |
| DB09037 | Pembrolizumab | 0 | Recruiting | 1 |
| DB14547 | Chloride ion | 1 | Recruiting | 1 |
| DB00515 | Cisplatin | 1 | Recruiting | 1 |
| DB00531 | Cyclophosphamide | 1 | Recruiting | 1 |
| DB00694 | Daunorubicin | 1 | Recruiting | 1 |
| DB00997 | Doxorubicin | 1 | Recruiting | 1 |
| DB00544 | Fluorouracil | 1 | Recruiting | 1 |
| DB00762 | Irinotecan | 1 | Recruiting | 1 |
| DB00650 | Leucovorin | 1 | Recruiting | 1 |
| DB00305 | Mitomycin | 1 | Recruiting | 1 |
| DB00526 | Oxaliplatin | 1 | Recruiting | 1 |
| DB01229 | Paclitaxel | 1 | Active Not Recruiting | 1 |
| DB09037 | Pembrolizumab | 1 | Recruiting | 1 |
| DB12257 | Platinum | 1 | Recruiting | 1 |
| DB00020 | Sargramostim | 1 | Recruiting | 1 |
| DB00531 | Cyclophosphamide | 1 / 2 | Completed | 1 |
| DB05643 | IRX-2 | 1 / 2 | Completed | 1 |
| DB09037 | Pembrolizumab | 1 / 2 | Completed | 1 |
| DB06599 | Lexatumumab | 2 | Recruiting | 1 |
| DB01229 | Paclitaxel | 2 | Recruiting | 1 |
| DB05578 | Ramucirumab | 2 | Recruiting | 1 |
| DB08937 | TAS-102 | 2 | Recruiting | 1 |
| DB09343 | Tipiracil | 2 | Recruiting | 1 |
| DB00432 | Trifluridine | 2 | Recruiting | 1 |
| DB00693 | Fluorescein | Not Available | Completed | 1 |